Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Bruno Paiva, Director Flow Cytometry Core at CIMA LAB Diagnostics, on X adding:
“Excellent work in Blood Cancer Journal by Martín-Sánchez, Bruno Paiva, et al.
You’ve seen their work on flow cytometry predicting MGUS-like vs not.
But now, flow cytometry to predict when to offer boosters to patients with multiple myeloma.”
Quoting Bruno Paiva’s post:
“New paper alert in Blood Cancer Journal.
Interest in immune response to infection and vaccines started during COVID19 and pivoted to a new research line in our lab!
Thanks L. Esteban Tamariz-Amador, Camila Guerrero, Paula Rodriguez-Otero, University of Navarra Clinic, Cima University of Navarra.”
Source: Rahul Banerjee/X and Bruno Paiva/X
Authors: Esperanza Martín-Sánchez, Luis-Esteban Tamariz-Amador, Camila Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesus F. San-Miguel, Paula Rodriguez-Otero, Bruno Paiva and The Basque-Navarra Association of Hematology and Hemotherapy (ASOVASNA) cooperative group.
